{"id":"NCT03084237","sponsor":"Shanghai Henlius Biotech","briefTitle":"Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast Cancer","officialTitle":"Double-blind, Randomized, Multicenter, Phase III Clinical Study to Compare the Efficacy and to Evaluate the Safety and Immunogenicity of Trastuzumab Biosimilar HLX02 and EU-sourced Herceptin® in Previously Untreated HER2 Overexpressing Metastatic Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-11","primaryCompletion":"2018-11-23","completion":"2021-09-28","firstPosted":"2017-03-20","resultsPosted":"2024-05-17","lastUpdate":"2024-05-17"},"enrollment":652,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"HLX02","otherNames":[]},{"type":"BIOLOGICAL","name":"Herceptin®","otherNames":[]},{"type":"DRUG","name":"docetaxel","otherNames":[]}],"arms":[{"label":"HLX02+Docetaxel","type":"EXPERIMENTAL"},{"label":"Herceptin®+Docetaxel","type":"ACTIVE_COMPARATOR"}],"summary":"This is a Phase III, double-blind, randomized multicenter study to compare the efficacy and to evaluate the safety and immunogenicity of HLX02 and European Union (EU)-sourced Herceptin® in patients with human epidermal growth factor receptor 2 (HER2)-positive, locally recurrent or previously untreated metastatic breast cancer.","primaryOutcome":{"measure":"ORR 24","timeFrame":"From time of First treatment to week 24","effectByArm":[{"arm":"HLX02+Docetaxel","deltaMin":71.1,"sd":null},{"arm":"Herceptin®+Docetaxel","deltaMin":70.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":21,"exclusionCount":11},"locations":{"siteCount":88,"countries":["China","Philippines","Ukraine"]},"refs":{"pmids":["39954568","33826080"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":78,"n":325},"commonTop":["White blood cell count decreased","Neutrophil count decreased","Alopecia","Anaemia","Aspartate aminotransferase increased"]}}